Yuyu Pharma, a company that values the pursuit of
improvement of human health and quality of life.
80 Years of Footsteps of Yuyu Pharma
80 Years of Footsteps
of Yuyu Pharma
A path in the pharmaceutical manufacturing business for the past 80 years with heart and tenderness for the family, not just customers, and a pioneering spirit for the future is the footsteps of Yuyu Pharma. We hope that it was a step toward improving quality of life of the people and the development of the Korean pharmaceutical industry. We, Yuyu Pharma, will do our best to pioneer a brighter future with 80 years of its history and tradition in mind.
Next 100 years, a starting point for a new future.
First Generick New Marco's cumulative sales surpass 40 million capsules.
Construction of new and renewable energy facilities in Jecheon plant
Introducing Covid-19 as a social contribution company to CNN
Appointment of CEO Yoo Won-sang as president
Foundation of Yuyu Medicals
Appointment of CEO of Yoo Won-sang
The 100th anniversary of the founder's distinguished chairman.
Asia-Pacific Small and Medium Innovation Pharmaceutical Company Selection
Seoul Office Building Remodeling Completed
Signed MOU with the Korea Osteoporosis Society and the Korea Women's Health and Osteoporosis Foundation
Chungcheongbuk-do Youth Job Selection
Opening Central research center expansion.
New Marco's Soft Capsules (First Generick) Released
Certification of excellent family-friendly enterprises by the Ministry of Gender Equality and Family
Commendation of MTI's best long-lived enterprises
With advanced systems and quality control of global production
Power to innovate management to lay the foundation for a 'second leap'
Selection of excellent employment enterprises on the 7th Chungbuk Businessmen's Day (Governor's Commendation)
China's Huanghua Group Signed an Export MOU
LOI signed with Bio-pharma in Malaysia
Osteoporosis drug Max Marville exports to Thailand
South Korea's pharmaceutical industry is the first to use big data marketing for Beno Plus Gel.
70th anniversary of its foundation, published 70th anniversary of Yuyu Pharmaceutical Co., Ltd.
Antidepressant generic drug 'Noyromine' released
Vitamin C 'Yupan Sea Pop' Released
Chuncheon Research Institute Opens
Umkamin Syrup, a cure for chronic respiratory infections, has been released.
Euclidean New Drug Development Research Association won the Technology Award for New Drug Development
Change the name to Yuyu Pharmaceutical
Anti-platelet improvement drug "Ucrid" released
Chairman Yoo Seung-pil receives Presidential Commendation on Taxpayer Day
intestinal medicine 'Schubaton' released
Zeller, Switzerland, contracts to introduce ZE440 for pre-menstrual and postmenstrual syndrome.
Transferring the construction of the Jecheon plant
Yuyu Healthcare Establishment
"Found a joint venture with Yuyu Teijin Medicare."
Osteoporosis treatment new drug "Max Marville" released
Chairman Yoo Seung-pil, National Medal of Merit, Moran Medal of Merit
Appointment of Chairman Yoo Seung-pil as Chairman of the Korea Pharmaceutical Association
Nasal cleanser, 'Fijiomer' released
Management innovation for diversification and globalization President Yoo Seung-pil's inauguration and internationalization strategy.
Technology partnership with Argentina's Gardo to release "Mavil Tab," a treatment for osteoporosis.
Acquisition of Korea's first manufacturing permit for Ginkgo Leaf X Injection System
Ginkgo Leaf X Acquires Quite a Patent
Japan's Taisho and Sowloon Copsell, a gastric ulcer drug, are released.
Germany's Dr. Willmar Schwabe to supply EGB761 to South Korea
Completion of the Seoul office building in Sindang-dong
The release of the biopharmaceutical drug 'Salbiwon' under an exclusive supply contract with Japan's Kokando Company.
Establishment of the Central Research Institute (Ministry of Science and Technology's 17th accreditation
YuYu Calmic Co., Ltd., a joint venture with Rentokil in the United Kingdom.Establishment
President Yoo Seung-pil takes office
Improve by attracting foreign capital, disclosure, and rationalization of management
Challenge to synthesize raw materials such as pars
Technical partnership with France's Sanofi group (released blood circulation enhancer 'Crid')
Technical partnership with Schwabe in West Germany (release of 'Tanamine' as a brain and peripheral circulatory improvement agent)
Yuyu Fumakilla Co., Ltd., a joint venture between Korea and Japan.
Technical partnership with Taisho, Japan (Released 'Linlaxa')
President Jeon Chang-ki takes office
Adopting the presidential system, taking office as president, Ko Kwang-soo
Technology partnership with Dainippon, Japan (Burutal State, an anemia treatment drug)
Technical partnership with Siegteied in Switzerland (Introduction of 'Spasla' in the Painful Economy)
Disclosure of enterprises, listing stocks, and establishment of trade unions;
Technical partnership with West Germany's Dr. Willmar Schwabe.
Technology partnership with Japan's Maiji seika (release of antibiotic "Meimycin")
Foundation of Yuyu Cultural Foundation
Korea-U.S. joint venture Korea Upjohn Ltd. Establishment
Technology partnership with U.S. UPZONE (Introducing new antibiotic drug "Lincosine")
'Yupan C A' is released.
Development of Yuyu Mechionine (Diel Mechionine) and release of 'Vina Polo A Soft Cap.'
Development of Vinapolo, Korea's first soft-capsell nutritional supplement
'Yupanssi' of vitamin C such release.
It took the lead in establishing 'Yuyu industry' and advancing pharmaceutical technology.
Development of 'Uvita'
Completion of Anyang Plant
Mutual change to oil industry corporation
Production of the first multi-vitamin-based vitamin system in Korea
Production of the psycho-neurodrug "Puranti"
Production of the tuberculosis drug "Eupaszit"
Changed its name to Yuhan Industrial Co., Ltd. and purchased its headquarters in Chungmu-ro, Jung-gu, Seoul, and started manufacturing medicine.
A president who is well versed in the health of his fellow countrymen.
Founder's Distinguished Chairman, Korea Pharmaceutical Industry Association
the election of the fourth president
The foundation of Yuyu Pharmaceutical Co., Ltd. (Limited Trading Co., Ltd.